Conviction
$ Value
$276K
Shares
25,000
Price
$11
Filed
Oct 27
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Kaplan Myron
Title
—
CIK
0001672645
Roles
Transaction Details
Transaction Date
2025-10-23
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
201,034
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.01 to $11.03, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. | The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Filing Info
Other Insiders at CRMD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| DUNTON ALAN W | — | — | 2026-01-26 |
| Lefkowitz Steven W | — | — | 2026-01-26 |
| Stewart Robert A | — | — | 2026-01-26 |
| Dillione Janet | — | — | 2026-01-26 |
| Kaplan Myron | — | — | 2026-01-26 |
|
Hurlburt Elizabeth
Chief Operating Officer
|
— | — | 2026-02-04 |
|
Todisco Joseph
Chief Executive Officer
|
— | — | 2026-02-04 |
|
Blum Susan
Chief Financial Officer
|
— | — | 2026-01-23 |
| Duncan Gregory Scott | — | — | 2026-01-26 |
|
Zelnick Kaufman Beth
Chief Legal Officer
|
— | — | 2026-02-04 |